🔭 Space, The Final Subscription Boss
Plus: Harvard’s Secret To Detecting 11 Cancers Early, THIS Tiny Company Riffed 42 Apps to the FDA – WTF?, and More
This week’s market, investing, and business insights from insiders and experts outside the mainstream media:
Starlink can easily become the world’s largest subscription business.
Harvard’s “secret weapon” detected 11 cancers early.
THIS tiny company riffed over 42 applications to the FDA—WTF?
A billion-dollar brand is copying Starbucks' entertainment playbook.
And more. Let’s get to it!
Follow us on Instagram | Advertise to our 7K+ subscribers
Top Insights of the Week
1. 🔭 Space, The Final Frontier Subscription Boss
Back in 2021, Elon Musk dropped this gem of a tweet…“Once we can predict cash flow reasonably well, Starlink will IPO”. It was shrugged off, Starlink was new.
Fast forward to 2023, “Excited to announce @Starlink hit breakeven cash flow...” Now, it’s clear. Elon’s about to make history again.
Starlink is set to make early believers a shit ton more money and take over the subscription business game.
Here’s why we’re paying close attention…
4M subscribers, paying ~$100/month.
$6.6B in revenue project for 2024.
~7,000 satellites, most out of any company.
SpaxeX's reusable rockets cut costs, fueling Starlink's growth.
Bringing high-speed internet to areas that never had it.
FEMA deploys Starlink for disaster support.
IPO on the horizon, second half of 2024 or into 2025.
Once satellite-to-phone tech becomes available, Starlink could easily 100x to 400M+ subscribers–making them one of the world’s largest subscription businesses. Nothing will come close.
The competition??? Nowhere to be found…
Amazon’s Project Kuiper, has only launched 2 prototype satellites.
Boeing may be looking to get out of the space industry all together.
2. 🤯 Harvard’s Secret To Detecting 11 Cancers Early
Harvard Medical School keeps the hits coming. Turning research into big ventures, like Editas Medicine using CRISPR and Sherlock Biosciences with cheap and rapid diagnostics tests. Now, they’re laser focused on another health crisis…Cancer.
Cancer diagnostics need consistency and accuracy—CHIEF, Harvard’s new AI model, delivers both.
What makes this a fascinating breakthrough?
CHIEF detected 19 cancers with 94% accuracy in 11.
Predicts tumors, survival rates, and treatment responses.
Analyzed 44TB of data and was tested on ~19K image from 24 hospitals.
Could this breakthrough position CHIEF for licensing or a major acquisition? Absolutely, that’s Harvard's playbook.
Harvard labs has spun out 100+ startups, raising $4.4B.
Other in the shadows research that could shake up biotech…
McMaster University, fighting germs that become immune to drugs
The Chinese University of Hong Kong, gut bugs that could potentially diagnose autism spectrum disorder (ASD) more quickly and accurately.
3. 💸 Ready to get serious about investing?
Then join our growing list of premium subscribers who have already placed themselves on the path to greater wealth by mirroring our stock ideas.
Subscribe today for just $9/month.
🚨 What you get when you become a premium subscriber ($13,890.80 value) 🚨
TOP 5 MARKET BEATING STOCK IDEAS ($5,000 value) picked with sniper precision, delivered to your inbox every Monday morning, before the market opens.
HIGH CONVICTION TRADE ALERTS ($1,690.80 value) throughout the week as we spot them.
Access to OUR COMMUNITY ($1,200 value) of fellow traders, where you can ask questions & post comments.
END OF THE MONTH SUMMARY ($600 value) of which ideas performed best.
NO GUESSWORK ($2,400 value). You'll get to see our entry point, stop loss, and profit target.
INSTANT ACCESS, no strings attached. No commitment. Cancel anytime.
UNCONVENTIONAL MARKET & MACRO INSIGHTS ($3,000 value), discover opportunities and risks not highlighted elsewhere.
MAKE MONEY or GET YOUR MONEY BACK GUARANTEE. If you subscribe today, use it actively for a year, and don't make money, we'll refund your payment and give you an extra year for free.
Get $13,890.80 worth of value for just $9/month to our premium newsletter. Hands down, Money Machine Newsletter is the most valuable investing service out there.
4. 🤨 THIS Tiny Company Riffed 42 Apps to the FDA – WTF?
A tiny unheard of company riffed over 42! applications to the FDA—they’re not messing around. Their competitor launched a similar product and the stock ballooned—pushing it to a 16-year high. Who’s the competitor? Philip Morris. And their darling product? Zyn…So, who wants to wet their beak and take some market share? Lucy.
Lucy submits 42 Premarket Tobacco applications to the FDA.
Here’s why we’re keeping a close eye on this one…
$10M raised in Series A from Y Combinator and RRE Ventures.
Uses lab-made nicotine, skipping the need for tobacco farming.
Innovation and FDA compliance make it a prime acquisition target.
Multiple products for adults craving a tobacco-free nicotine.
Lucy’s following Zyn’s playbook, which made Philip Morris’ stock boom. Their innovation and FDA compliance put them in the crosshairs for a potential MAJOR acquisition or IPO.
Tobacco-free nicotine market: ~$3B in 2023, projected ~$23B by 2030.
Community Spotlight
Newsletters from other independent thinkers you might find interesting.
👉 Liberty and Tea, weekly newsletter discussing life, liberty, and the pursuit of happiness.
👉 Panic Drop, learn to profit from market panic and master the art of combining stocks with crypto!
👉 Bitcoin Fortress Newsletter, empowering your journey towards financial freedom through the lens of Bitcoin wisdom.
👉 ThirdSpace Buzz, unlock your entrepreneurial potential: a newsletter for visionaries, innovators, and leaders.
Top 3 Charts of the Week
1. 🐔 Chick-fil-A’s Chicken Sales Keep Soaring
Chick-fil-A launches Chick-fil-A Play on Nov 18, with shows, podcasts, and games for families.
With $21.6B in sales, they’re following brands like Starbucks into media.
Companies are blending products with entertainment to stay connected.
2. 😓 Most Teens Feel Pressure to Have a Plan
Teens spend 5 hours per day on social media, pressured by nonstop hustle posts.
81% feel stressed, 27% are burned out, and 56% worry about their future.
3. ⚡️ Red Bull Remains the King of Energy Drinks
Keurig is expanding beyond coffee, buying most of Ghost, an energy drink brand, for $1B.
They’re taking on giants…
Red Bull (~$11.4B sales in 2023)
Monster (~$7.1B sales in 2023)
Celsius (~$1.3B sales in 2023)
Prime (~$1.2B sales in 2023)
Energy drinks grew 10% last year.
What did you think of today’s newsletter?
Enjoy this content? Subscribe to our Instagram
We take the responsibility of emailing you seriously. If you don't want to receive stock market updates and trading education anymore, you can unsubscribe at any time.
Nothing in this email is intended to serve as financial advice. Do your own research. See important disclaimer & terms of service.